Abstract
In a nutshellCarnitine has been trialled as treatment for fatigue in a number of conditions, including renal dialysis, CFS and cancer.The trend of results from these trials has been positive. But limitations in sample size, duration and design means the data collectively does not yet add up to a convincing case either way. Safety has so far not been a problem.
Publisher
Cambridge University Press (CUP)